Urologic Surgical Oncology Clinic
Patients at the UCSF Urologic Surgical Oncology Clinic have access to some of the leading urologic cancer specialists in the country. We provide a wide range of services, including screening exams, diagnostic imaging, transrectal ultrasound and biopsy, second opinions and treatments ranging from surgery to radiation therapy. We also offer patient education and support groups.
UCSF is home to a large research program dedicated to improving cancer prevention, diagnosis and treatment. Interested patients may have the option to join a clinical trial investigating potential new treatments.
Learn more about clinical trials and how they work.
Our locations
Other UCSF cancer care options near you (3)
UCSF-John Muir Health Cancer Center in Berkeley
Cancer Center Redwood City
Our team
Clinical trials
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
To estimate PPVs of age-based PSA thresholds for biopsy referral in this patient population, will first fit a logistic regression model to estimate the odds that biopsy leads to a prostate cancer diagnosis. The regression will hav...
Recruiting
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomograp...
Negative predictive value (NPV): The NPV is defined as the number of negative image results with identified clinically insignificant prostate cancer on biopsy divided by the number of negative image results.
Recruiting
PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer
The proportion of participants with prostate cancer in whom PYLARIFY PET detected previously occult intraprostatic ISUP grade ≥3 lesions as assessed by pathology, or in whom PYLARIFY PET detected the presence of either/or extrapro...
Recruiting
Rankings & achievements
-
Among the top hospitals in the nation
-
Best in Northern California and No. 7 in the nation for cancer care
-
Best in Northern California for urology
-
in NIH funding for urology research
Accreditations & memberships
-
National Cancer Institute
The National Cancer Institute has designated UCSF a comprehensive cancer center, its highest ranking. This designation is awarded to centers that demonstrate scientific excellence and the ability to conduct cancer research across many disciplines.
-
Commission on Cancer
UCSF's cancer programs have been accredited by the American College of Surgeons' Commission on Cancer (CoC) since 1933. The CoC is a consortium of groups dedicated to improving cancer patients' survival and quality of life via research, education and better medical care.
-
National Comprehensive Cancer Network
UCSF is a member of the National Comprehensive Cancer Network, an alliance of the world’s top cancer centers. The network brings together leaders in treatment and research to improve the quality, effectiveness and efficiency of cancer care.
Support services
Plan your visit
What to Bring
- Recent radiology reports and scans, including X-rays, magnetic resonance images (MRIs) and ultrasound films or CDs, that relate to your condition, as well as written reports that accompany those films
- Pathology reports of any biopsies or tests. Please bring glass pathology slides from the lab or office where the test was performed.
- Copies of all records relevant to your condition, including your last laboratory report and the most recent report or dictation from the doctor who referred you to UCSF. This may include records from your primary care physician, oncologist or surgeon.
- Copies of your insurance cards
- A list of all your doctors, including their mailing addresses and telephone and fax numbers
Related clinics
Our research initiatives
-
UCSF Department of Urology Cancer Research
The UCSF Department of Urology is internationally known for its research in prostate and other urological cancers.
-
UCSF Helen Diller Family Comprehensive Cancer Center Research
UCSF is home to a range of research initiatives aimed at improving outcomes for cancer patients everywhere. This includes research on topics such as immunotherapy, BRCA mutations and molecular diagnostic testing.